Nat Genet:日本研究人员发现日光过敏症致病基因

2012-04-10 蓝建中 新华网

日本一个研究小组日前宣布,他们发现紫外线敏感性综合征的一个致病基因,这一发现将有助于今后弄清人的皮肤被晒伤的机制,从而研究出相关防晒伤的新方法。该成果已于4月1日在线刊登在《Nature Genetics》上。 日本长崎大学和佳丽宝公司的联合研究小组在东京宣布,这项研究开展于2010年7月,他们通过利用能在短时间内对人类基因组DNA序列进行解析的最新技术——下一代基因序列解析法,确定了一个可能是

日本一个研究小组日前宣布,他们发现紫外线敏感性综合征的一个致病基因,这一发现将有助于今后弄清人的皮肤被晒伤的机制,从而研究出相关防晒伤的新方法。该成果已于4月1日在线刊登在《Nature Genetics》上。

日本长崎大学和佳丽宝公司的联合研究小组在东京宣布,这项研究开展于2010年7月,他们通过利用能在短时间内对人类基因组DNA序列进行解析的最新技术——下一代基因序列解析法,确定了一个可能是紫外线敏感性综合征患者致病原因的基因变异。研究人员发现,由于这个基因出现变异,导致无法产生对受损的DNA进行快速修复的蛋白质,或者产生的量非常少,研究小组将这种基因命名为UVSSA。研究人员对紫外线敏感性综合征患者进行基因修复后,肌体对DNA进行快速修复的功能恢复到了与健康人同等的水平。

研究人员高桥庆人指出,紫外线敏感性综合征除了强烈日晒症状外基本没有其他症状,是一种轻度的遗传性光敏性疾病,发现30多年来其致病原因一直未解。今后通过对该基因进行详细分析,将有助于开发出防止皮肤被晒伤的新方法。(生物谷 bioon.com)

doi:10.1038/ng.2229
PMC:
PMID:

Mutations in UVSSA cause UV-sensitive syndrome and impair RNA polymerase IIo processing in transcription-coupled nucleotide-excision repair

Yuka Nakazawa,Kensaku Sasaki,Norisato Mitsutake,Michiko Matsuse,Mayuko Shimada,Tiziana Nardo,Yoshito Takahashi,Kaname Ohyama,Kosei Ito,Hiroyuki Mishima,Masayo Nomura,Akira Kinoshita,Shinji Ono,Katsuya Takenaka,Ritsuko Masuyama,Takashi Kudo,Hanoch Slor,Atsushi Utani,Satoshi Tateishi,Shunichi Yamashita,Miria Stefanini,Alan R Lehmann,Koh-ichiro Yoshiura, Tomoo Ogi

UV-sensitive syndrome (UVSS) is a genodermatosis characterized by cutaneous photosensitivity without skin carcinoma. Despite mild clinical features, cells from individuals with UVSS, like Cockayne syndrome cells, are very UV sensitive and are deficient in transcription-coupled nucleotide-excision repair (TC-NER) which removes DNA damage in actively transcribed genes6. Three of the seven known UVSS cases carry mutations in the Cockayne syndrome genes ERCC8 or ERCC6 (also known as CSA and CSB, respectively). The remaining four individuals with UVSS, one of whom is described for the first time here, formed a separate UVSS-A complementation group; however, the responsible gene was unknown. Using exome sequencing11, we determine that mutations in the UVSSA gene (formerly known as KIAA1530) cause UVSS-A. The UVSSA protein interacts with TC-NER machinery and stabilizes the ERCC6 complex; it also facilitates ubiquitination of RNA polymerase IIo stalled at DNA damage sites. Our findings provide mechanistic insights into the processing of stalled RNA polymerase and explain the different clinical features across these TC-NER–deficient disorders.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1907398, encodeId=6d3d190e3981d, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jan 12 06:49:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879180, encodeId=63d918e9180f1, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 19 21:49:00 CST 2012, time=2012-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685851, encodeId=e6391685851d4, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Tue May 08 13:49:00 CST 2012, time=2012-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733590, encodeId=2d261e3359010, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Nov 14 05:49:00 CST 2012, time=2012-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048428, encodeId=e30320484288d, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Dec 05 02:49:00 CST 2012, time=2012-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294111, encodeId=2bc91294111b8, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488483, encodeId=1c1e148848333, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516431, encodeId=a747151643162, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1907398, encodeId=6d3d190e3981d, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jan 12 06:49:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879180, encodeId=63d918e9180f1, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 19 21:49:00 CST 2012, time=2012-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685851, encodeId=e6391685851d4, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Tue May 08 13:49:00 CST 2012, time=2012-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733590, encodeId=2d261e3359010, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Nov 14 05:49:00 CST 2012, time=2012-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048428, encodeId=e30320484288d, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Dec 05 02:49:00 CST 2012, time=2012-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294111, encodeId=2bc91294111b8, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488483, encodeId=1c1e148848333, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516431, encodeId=a747151643162, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-06-19 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=1907398, encodeId=6d3d190e3981d, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jan 12 06:49:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879180, encodeId=63d918e9180f1, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 19 21:49:00 CST 2012, time=2012-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685851, encodeId=e6391685851d4, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Tue May 08 13:49:00 CST 2012, time=2012-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733590, encodeId=2d261e3359010, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Nov 14 05:49:00 CST 2012, time=2012-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048428, encodeId=e30320484288d, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Dec 05 02:49:00 CST 2012, time=2012-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294111, encodeId=2bc91294111b8, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488483, encodeId=1c1e148848333, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516431, encodeId=a747151643162, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1907398, encodeId=6d3d190e3981d, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jan 12 06:49:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879180, encodeId=63d918e9180f1, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 19 21:49:00 CST 2012, time=2012-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685851, encodeId=e6391685851d4, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Tue May 08 13:49:00 CST 2012, time=2012-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733590, encodeId=2d261e3359010, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Nov 14 05:49:00 CST 2012, time=2012-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048428, encodeId=e30320484288d, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Dec 05 02:49:00 CST 2012, time=2012-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294111, encodeId=2bc91294111b8, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488483, encodeId=1c1e148848333, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516431, encodeId=a747151643162, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-11-14 canlab
  5. [GetPortalCommentsPageByObjectIdResponse(id=1907398, encodeId=6d3d190e3981d, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jan 12 06:49:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879180, encodeId=63d918e9180f1, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 19 21:49:00 CST 2012, time=2012-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685851, encodeId=e6391685851d4, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Tue May 08 13:49:00 CST 2012, time=2012-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733590, encodeId=2d261e3359010, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Nov 14 05:49:00 CST 2012, time=2012-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048428, encodeId=e30320484288d, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Dec 05 02:49:00 CST 2012, time=2012-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294111, encodeId=2bc91294111b8, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488483, encodeId=1c1e148848333, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516431, encodeId=a747151643162, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-12-05 cy0324
  6. [GetPortalCommentsPageByObjectIdResponse(id=1907398, encodeId=6d3d190e3981d, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jan 12 06:49:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879180, encodeId=63d918e9180f1, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 19 21:49:00 CST 2012, time=2012-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685851, encodeId=e6391685851d4, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Tue May 08 13:49:00 CST 2012, time=2012-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733590, encodeId=2d261e3359010, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Nov 14 05:49:00 CST 2012, time=2012-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048428, encodeId=e30320484288d, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Dec 05 02:49:00 CST 2012, time=2012-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294111, encodeId=2bc91294111b8, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488483, encodeId=1c1e148848333, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516431, encodeId=a747151643162, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1907398, encodeId=6d3d190e3981d, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jan 12 06:49:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879180, encodeId=63d918e9180f1, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 19 21:49:00 CST 2012, time=2012-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685851, encodeId=e6391685851d4, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Tue May 08 13:49:00 CST 2012, time=2012-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733590, encodeId=2d261e3359010, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Nov 14 05:49:00 CST 2012, time=2012-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048428, encodeId=e30320484288d, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Dec 05 02:49:00 CST 2012, time=2012-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294111, encodeId=2bc91294111b8, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488483, encodeId=1c1e148848333, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516431, encodeId=a747151643162, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1907398, encodeId=6d3d190e3981d, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jan 12 06:49:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879180, encodeId=63d918e9180f1, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 19 21:49:00 CST 2012, time=2012-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685851, encodeId=e6391685851d4, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Tue May 08 13:49:00 CST 2012, time=2012-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733590, encodeId=2d261e3359010, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Nov 14 05:49:00 CST 2012, time=2012-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048428, encodeId=e30320484288d, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Dec 05 02:49:00 CST 2012, time=2012-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294111, encodeId=2bc91294111b8, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488483, encodeId=1c1e148848333, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516431, encodeId=a747151643162, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Thu Apr 12 14:49:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]

相关资讯

Phy Med Bio:X射线对于肥胖人群的危害

Big job (Image: Living Art Enterprises, LLC/Science Photo Library) 近日,国际著名杂志Physics in Medicine and Biology在线刊登了国外研究人员的最新研究成果“Extension of RPI-adult male and female computational phantoms to obese pa

PNAS:科学家发现新的免疫防御酶

中性粒细胞是组成免疫系统的重要一部分。当病原菌侵入我们身体时,中性粒细胞都会在第一时间赶赴感染现场,通过信号分子调集其他免疫细胞从而保护我们机体。为此,中性粒细胞释放丝氨酸蛋白酶,激活信号分子。近日,Martinsried的马克斯·普朗克神经生物学研究所的科学家们发现一种新的丝氨酸蛋白酶:中性粒细胞丝氨酸蛋白酶4,或NSP4。这种酶为治疗免疫系统疾病如类风湿关节炎等提供一个新治疗策略。 免疫系统

JN:唾液中的酶有助于调节血糖

莫内尔中心科学家发表报告称:摄取淀粉后体内的血糖水平是由唾液淀粉酶调控的,唾液淀粉酶能够分解饮食中的淀粉成分。具体来说就是较高的唾液淀粉酶活性能降低血糖水平。 这项研究结果首次证明在淀粉消化过程中唾液淀粉酶的重要代谢作用,结果提示唾液淀粉酶可能有助于改善整体代谢状况。该研究特出之处在于计算含丰富淀粉食物的血糖指数以及最终患上糖尿病的风险。 论文主要作者、莫内尔营养科学家Abigail Mand

Biol Psychiat :睾酮的抗抑郁机制被阐明

男性主要性激素——睾酮,表现出有抗抑郁药的性能,但其作用的确切机制仍不清楚。佛罗里达州立大学Nicole Carrier和Mohamed Kabbaj科学家们正在积极开展研究工作以弄清睾酮抗抑郁的机制。 研究人员已经发现,大脑海马区域参与记忆的形成和调节应激反应的特定信号途径在睾酮发挥抗抑郁过程中起着重要的作用,相关研究结果发表在《生物精神病学》杂志上。 与男性相比,女性患抑郁症的可能性高出了

Fertil Steril:美国研究提示女性应正确认识晚育风险

耶鲁大学的一篇研究报告称,许多的女性并没有完全认识到晚育的后果,并且还期望辅助生育技术能够扭转她们已经衰退的卵巢功能。该文章3月5日在线发表于Fertility and Sterility。 “在女性中存在着令人担忧的生育误解,”耶鲁医学院的Pasquale Patrizio教授说。“我们还发现,女性缺乏相关的知识,不知道在生育年龄可采取哪些措施以维持以后怀孕的可能性。” 该报告源自于Patr

Cell Stem Cell:慢性髓样白血病治疗的新途径

近日,研究者在4月出版的杂志Cell Stem Cell上发布了他们的最新研究成果,文章中,研究者通过在小鼠体内进行实验,发现了一种可以有效阻止白血病干细胞的方法,研究者建议联合的治疗方法可以有效的捣毁慢性髓样白血病(chronic myeloid leukemia,CML)。很多慢性髓样白血病人总是在重复经历着癌症的再次光顾,因为病人机体内部残存着逗留不去的白血病干细胞,白血病干细胞可以顽固地存